Here are 3 dividend shares I would buy in April

The ASX Ltd (ASX:ASX) dividend is one of three which I think income investors should consider snapping up in April. Here's why…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

With term deposits and savings accounts offering just paltry interest rates, I think investors would be better served with an investment in one of the many high-yielding dividend shares on the Australian share market.

Three shares which would be at the top of my shopping list in April are as follows:

ASX Ltd (ASX: ASX)

One key reason I like the operator of the Australian stock exchange is its near-monopoly status. This has allowed the company to successfully grow its bottom line each year for the last five years. Following a solid first-half, I expect another year of growth ahead for both its earnings and its dividend. At present ASX's shares provide a trailing fully franked 4.1% dividend.

Event Hospitality and Entertainment Ltd (ASX: EVT)

At the current share price Event provides investors with a trailing fully franked 4.2% dividend. Thanks to the tailwinds of the Australian tourism boom, I believe the company is positioned perfectly for growth thanks to its popular entertainment and accommodation brands such as Event Cinema, Rydges, and Thredbo Alpine Resort. With its shares down 20% in the last 12 months, I think now could be an opportune time to make a buy and hold investment.

Sigma Pharmaceutical Limited (ASX: SIP)

Sigma is the company behind pharmacy chain brands such as Amcal, Chemist King, and Guardian. Last week the company reported a 13% jump in full-year underlying net profit after tax to $66.9 million. Despite its shares rallying after the result, they are still changing hands at 20x earnings and provide a trailing fully franked 4.5% dividend. I believe this makes it a great option for investors, especially with the progress it is making with its online store in China.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »